Taylor Wessing

Jointly led by Ross McNaughton and Adrian Toutoungi in Cambridge, Taylor Wessing’s practice is well-known for handling the full spectrum of mandates within the biotech industry, particularly relating to AI. McNaughton is a key contact for public capital raising, M&A, and venture financing mandates within the diagnostics, digital health, and medical device spaces. Toutoungi is recommended for his longstanding experience in assisting biologics, gene therapy, and small-molecule therapeutics clients with licensing and distribution issues. Dividing his time between Cambridge and London, Colin McCall is noted for his work concerning R&D projects and collaboration agreements. Key members of the team include Charlie Adams, who focuses on IP commercialisation within the life sciences space, and Oli Denne, who specialises in venture capital fundraising mandates.